Literature DB >> 15031321

Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin.

Annie Lacerte1, Eun-Hye Lee, Rachel Reynaud, Lucie Canaff, Chantal De Guise, Dominic Devost, Suhad Ali, Geoffrey N Hendy, Jean-Jacques Lebrun.   

Abstract

Activin, a member of the TGFbeta superfamily, is a negative regulator of cell growth and prolactin (PRL) production in pituitary lactotrope cells. However, the mechanisms by which this growth factor exerts its growth-inhibitory and -repressive effect on PRL remain unclear. In this study, we show that activin negatively regulates PRL expression at the transcriptional level through the Smad pathway and the multiple endocrine neoplasia type 1 gene product, menin. Our results also demonstrate that the tumor suppressor menin is required for activin-induced growth arrest of somatolactotrope cells. Moreover, we show that activin represses transcription and expression of Pit-1, a pituitary transcription factor that is essential for maintenance and development of lactotrope cells. We defined two Pit-1 DNA-binding sites in the proximal region of the PRL promoter as critical for the activin-mediated inhibition. Together, our results highlight the Smad pathway and the tumor suppressor menin as key regulators of activin effects on PRL and Pit-1 expression, as well as on cell growth inhibition, and emphasize the critical role of activin in the regulation of pituitary function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031321     DOI: 10.1210/me.2003-0470

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Lucie Canaff; Jean-François Vanbellinghen; Hiroshi Kaji; David Goltzman; Geoffrey N Hendy
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Myostatin regulates pituitary development and hepatic IGF1.

Authors:  Wioletta Czaja; Yukiko K Nakamura; Naisi Li; Jennifer A Eldridge; David M DeAvila; Thomas B Thompson; Buel D Rodgers
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-19       Impact factor: 4.310

3.  Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Authors:  Z Hamze; C Vercherat; A Bernigaud-Lacheretz; W Bazzi; R Bonnavion; J Lu; A Calender; C Pouponnot; P Bertolino; C Roche; R Stein; J Y Scoazec; C X Zhang; M Cordier-Bussat
Journal:  Endocr Relat Cancer       Date:  2013-10-24       Impact factor: 5.678

4.  The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.

Authors:  Allyson K Roof; Siwanon Jirawatnotai; Tammy Trudeau; Crystal Kuzyk; Margaret E Wierman; Hiroaki Kiyokawa; Arthur Gutierrez-Hartmann
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

5.  Pituitary somatolactotropes evade an oncogenic response to Ras.

Authors:  Allyson K Roof; Tammy Trudeau; Arthur Gutierrez-Hartmann
Journal:  Mol Cell Endocrinol       Date:  2018-05-09       Impact factor: 4.102

6.  Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter.

Authors:  Damiana Giacomini; Marcelo Páez-Pereda; Johanna Stalla; Günter K Stalla; Eduardo Arzt
Journal:  Mol Endocrinol       Date:  2009-04-02

Review 7.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

Review 8.  The role of genetic and epigenetic changes in pituitary tumorigenesis.

Authors:  Hidenori Fukuoka; Yutaka Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-11-29       Impact factor: 1.742

Review 9.  Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Authors:  Cornelis J Lips; Koen M Dreijerink; Jo W Höppener
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 10.  The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis.

Authors:  Jean-Jacques Lebrun
Journal:  ISRN Mol Biol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.